HAG
HighPoint Advisor Group’s ResMed RMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $545K | Buy |
2,112
+17
| +0.8% | +$4.39K | 0.03% | 356 |
|
|
2025
Q1 | $498K | Sell |
2,095
-475
| -18% | -$113K | 0.03% | 359 |
|
|
2024
Q4 | $610K | Buy |
2,570
+64
| +3% | +$15.2K | 0.03% | 332 |
|
|
2024
Q3 | $612K | Buy |
2,506
+64
| +3% | +$15.6K | 0.04% | 322 |
|
|
2024
Q2 | $508K | Buy |
2,442
+11
| +0.5% | +$2.29K | 0.03% | 346 |
|
|
2024
Q1 | $530K | Buy |
2,431
+19
| +0.8% | +$4.14K | 0.04% | 338 |
|
|
2023
Q4 | $466K | Buy |
+2,412
| New | +$466K | 0.03% | 367 |
|
|
2022
Q2 | $419K | Buy |
+1,928
| New | +$419K | 0.05% | 321 |
|
|
2021
Q3 | $506K | Buy |
1,918
+73
| +4% | +$19.3K | 0.05% | 305 |
|
|
2021
Q2 | $455K | Buy |
1,845
+355
| +24% | +$87.5K | 0.05% | 322 |
|
|
2021
Q1 | $297K | Buy |
1,490
+160
| +12% | +$31.9K | 0.03% | 372 |
|
|
2020
Q4 | $266K | Buy |
1,330
+50
| +4% | +$10K | 0.03% | 376 |
|
|
2020
Q3 | $272K | Buy |
1,280
+98
| +8% | +$20.8K | 0.05% | 292 |
|
|
2020
Q2 | $226K | Sell |
1,182
-57
| -5% | -$10.9K | 0.05% | 294 |
|
|
2020
Q1 | $199K | Buy |
+1,239
| New | +$199K | 0.05% | 301 |
|
|
2019
Q4 | – | Sell |
-1,167
| Closed | -$167K | – | 455 |
|
|
2019
Q3 | $167K | Buy |
1,167
+4
| +0.3% | +$572 | 0.04% | 346 |
|
|
2019
Q2 | $143K | Buy |
+1,163
| New | +$143K | 0.03% | 368 |
|